QQCWB

GV

Drug Dependence Unodc-Who Programme. Treatment And Care

Di: Ava

Drug dependence is considered a multi-factorial health disorder that often follows the course of a relapsing and remitting chronic disease. Given the individual and socio-economic burden inflicted by drug dependence, the effective treatment and rehabilitation of patients is of significant public health importance. Global public health approaches in drug dependence treatment and care The UNODC Drug Dependence Treatment and Rehabilitation unit is currently implementing three global projects, which aim at supporting Member States in their efforts to provide evidence-based drug dependence treatment services for individuals affected by drug use disorders, with special focus on low and middle-income countries.

It maximizes the impact and effective use of resources, whilst harnessing the strengths and mandates of each organization. One example of this collaboration is the UNODC-WHO Programme on Drug Dependence Treatment and Care (GLOK32), a global implementation platform, which is being managed under the joint leadership of UNODC and WHO. Both the WHO and UNODC strive to address the complex issues presented by drug use and dependence. 11 March 2009 – UNODC and the World Health Organization (WHO) are launching a Joint Programme on Drug Dependence Treatment and Care today, at a side event to the High-Level Segment of the ongoing UN Commission on Narcotic Drugs. The programme will lead a global collaborative effort for improving coverage and quality of treatment and care services for drug

drug dependence UNODC-WHO programme. treatment and care

Drug Prevention Treatment and Care

Reflecting on 2024, the United Nations Office on Drugs and Crime (UNODC) collective action and shared commitment drove significant advancements in delivering accessible, ethical, and effective drug use disorder treatment and care around the globe. From scaling up treatment services to collaborating with health and justice sectors, these efforts have helped The S-O-S initiative, which is implemented in the framework of the UNODC-WHO Programme on Drug Dependence Treatment and care, aims at the mobilization of a broad range of partners including governments, healthcare providers, people with drug use disorders and their peers, family members, people in local communities as well as non-governmental The WHO-UNODC survey was developed as part of the UNODC-WHO Programme on Drug Dependence Treatment and Care for the purpose of mapping the substance use disorder treatment services in a given country (UNODC, 2018d).

Competencies: Professionalism: Knowledge of approaches, tools, and methodologies essential to plan, implement and monitor a project aiming at increased availability and accessibility of evidence-based drug dependence treatment and care (including HIV and AIDS prevention and care) services; ability to produce a variety of written communication products in a clear and

The UNODC-WHO Programme on Drug Dependence Treatment and Care, (GLOK32) was established in 2009 to offer support to countries in relation to drug dependence treatment. UNODC promotes and supports evidence-based and ethical treatment policies, strategies and interventions worldwide, with a particular focus on low- and middle-income countries, to reduce the health and social burden caused by drug use and drug use disorders through the UNODC/WHO Programme on Drug Dependence Treatment and Care. The Joint UNODC-WHO Programme on Drug Dependence Treatment and Care is a collaboration between UNODC and WHO to support the development of comprehensive, integrated health-based approaches to drug policies that can reduce demand for illicit substances, relieve suffering and decrease drug-related harm to individuals, families, communities and

The UNODC Drug Dependence Treatment and Rehabilitation unit has produced and continues to develop a wide range of quality publications, standards and tools that allow for effective dissemination and exchange of technical knowledge and available information on the topic of drug dependence treatment and care.

Drug dependence is considered a multi-factorial health disorder that often follows the course of a relapsing and remitting chronic disease. Unfortunately in many societies drug dependence is still not recognized as a health problem and many people suffering from it are stigmatized and have no access to treatment and rehabilitation. Over recent years, the biopsychosocial model has

  • Publications on drug prevention and treatment
  • Independent Mid-term In-depth Cluster Evaluation of
  • UNODC-WHO Joint Programme on drug dependence treatment and care

Drug use disorders often take the course of a chronic and relapsing health disorder. UNODC supports UN Member States in their efforts to develop and expand ethical, effective, and accessible drug use disorder treatment and care services in a public health framework, in line with International Standards for the Treatment of Drug Use Disorders. Evidence-based treatment However, access to HIV prevention, treatment and care programmes is often lacking in prisons and other closed settings. Few countries imple-ment comprehensive HIV prevention, treatment and care programmes in prisons. Many fail to link their programmes in prisons to the national AIDS, tuberculosis or public health programmes. Many fail to provide adequate occupational

Drug dependence is considered a multi-factorial health disorder that often follows the course of a relapsing and remitting chronic disease. Given the individual and socio-economic burden inflicted by drug dependence, the effective treatment and rehabilitation of patients is of significant public health importance. Global public health approaches in drug dependence treatment and care Both the WHO and UNODC strive to address the complex issues presented by drug use and dependence.

Overview The International Standards for the Treatment of Drug Use Disorders was prepared by World Health Organization (WHO) and United Nations Office on Drugs and Crime (UNODC) to support Member States in developing and expanding effective, evidence-based and ethical treatment for drug use disorders, especially in less-resourced

Drug dependence is considered a multi-factorial health disorder that often follows the course of a relapsing and remitting chronic disease. Given the individual and socio-economic burden inflicted by drug dependence, the effective treatment and rehabilitation of patients is of significant public health importance. Global public health approaches in drug dependence treatment and care

The publication was invited by resolution 58/5 of the Commission on Narcotic Drugs entitled “Supporting the collaboration of public health and justice authorities in pursuing alternative measures to conviction or punishment for appropriate drug related offences of a minor nature”. In response to this, UNODC and WHO launched the initiative “Treatment and Care of UNODC and WHO jointly established a Global Programme on Drug Dependence Treatment and Care to support evidence-based and ethical treatment policies, strategies and interventions to reduce the health and social burden caused by drug use disorders.

Drug dependence is considered a multi-factorial health disorder that often follows the course of a relapsing and remitting chronic disease. Given the individual and socio-economic burden inflicted by drug dependence, the effective treatment and rehabilitation of patients is of significant public health importance. Global public health approaches in drug dependence treatment and care The Joint UNODC-WHO Programme on Drug Dependence Treatment and Care is a collaboration between UNODC and WHO to support the development of comprehensive, integrated health-based approaches to drug policies that can reduce demand for illicit substances, relieve suffering and decrease drug-related harm to individuals, families, communities and Under the umbrella of the UNODC-WHO Programme on Drug Dependence Treatment and Care and the S-O-S Initiative, a UNODC-WHO Multi-site Study on community management of opioid overdose, including emergency naloxone, is currently being developed and key elements of the study protocol are presented here.

Tunisia Draws Inspiration from Algeria’s Methadone Programme: Advancing Drug Dependence Treatment and Care Through South-South Cooperation true true Imagine a future where addiction is no longer a certainty, where treatment is

Countering transnational organized crime and illicit trafficking/drug trafficking Prevention, treatment and reintegration, and alternative development Convention against the Illicit Traffic in Narcotic Drugs and Psychotropic Substances Information on funding opportunities and the recipient organizations The programme is based on a global collaborative effort, under the leadership of UNODC and WHO. The collaboration will include governments, health professionals, non-governmental organizations (NGOs) and funding agencies committed to increasing the coverage of essential services for drug dependence treatment and care. Why UNODC and WHO together? The Joint Programme encourages investment in comprehensive results-oriented programmes for drug dependence treatment and care, particularly community-based interventions. The dominant response in Southeast Asia to drug use and dependence is compulsory centres for drug users.

Drug dependence is considered a multi-factorial health disorder that often follows the course of a relapsing and remitting chronic disease. Given the individual and socio-economic burden inflicted by drug dependence, the effective treatment and rehabilitation of patients is of significant public health importance. Global public health approaches in drug dependence treatment and care CBTx Community Based Treatment refers to a specific integrated model of treatment for people affected by drug use and dependence in the community which provides a continuum of care from outreach and low threshold services, through detoxification and stabilisation to aftercare and integration, including maintenance pharmacotherapy. It involves the coordination of a number The UNODC Drug Dependence Treatment and Rehabilitation unit has produced and continues to develop a wide range of quality publications, standards and tools that allow for effective dissemination and exchange of technical knowledge and available information on the topic of drug dependence treatment and care.

UNODC Drug Treatment and Care Join our #ScaleUp Initiative Nick Danziger for UNODC Programme for Drug Dependence Treatment and Care The UNODC Prevention, Treatment and Rehabilitation Section works with Member States to address the world drug problem through a balanced approach that is effective in increasing the health and safety of individuals and communities, in line with ethical standards. Prevention of drug use and other risky behaviours Treatment, health care, social protection and rehabilitation

From Coercion to Cohesion: treating drug dependence through heath care, not punishment This discussion paper outlines a model for referral from the criminal justice system to the treatment system that is more effective than compulsory treatment and which results in less restriction of liberty, less stigma and better prospects for the future of the individual and society. Available in